Anavex Life Sciences (AVXL) had the highest return between June 1, 2015 and July 31, 2015 by a US stock with a market cap of $100M+, returning 130.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Anavex Life Sciences (AVXL) | 6/1/2015 - 7/31/2015 | 130.41% |
Tvardi Therapeutics (TVRD) | 6/1/2015 - 7/31/2015 | 124.32% |
Rocket Pharmaceuticals (RCKT) | 6/1/2015 - 7/31/2015 | 122.81% |
Anixa Biosciences (ANIX) | 6/1/2015 - 7/31/2015 | 95.21% |
DBV Technologies (DBVT) | 6/1/2015 - 7/31/2015 | 83.31% |
Ardelyx (ARDX) | 6/1/2015 - 7/31/2015 | 79.76% |
Skeena Resources (SKE) | 6/1/2015 - 7/31/2015 | 74% |
Teladoc (TDOC) | 6/1/2015 - 7/31/2015 | 66.16% |
Exelixis (EXEL) | 6/1/2015 - 7/31/2015 | 64.66% |
Prothena (PRTA) | 6/1/2015 - 7/31/2015 | 62.65% |
Achieve Life Sciences (ACHV) | 6/1/2015 - 7/31/2015 | 59.72% |
LightPath Technologies (LPTH) | 6/1/2015 - 7/31/2015 | 58% |
Precigen (PGEN) | 6/1/2015 - 7/31/2015 | 53.82% |
TON Strategy (TONX) | 6/1/2015 - 7/31/2015 | 53.08% |
Heron Therapeuti (HRTX) | 6/1/2015 - 7/31/2015 | 52.98% |
Quantum Computing (QUBT) | 6/1/2015 - 7/31/2015 | 50% |
Flotek Industries (FTK) | 6/1/2015 - 7/31/2015 | 48.35% |
SUI (SUIG) | 6/1/2015 - 7/31/2015 | 48.32% |
Atlanticus (ATLC) | 6/1/2015 - 7/31/2015 | 48.29% |
Supernus Pharmaceuticals (SUPN) | 6/1/2015 - 7/31/2015 | 47.5% |
Coherus BioSciences (CHRS) | 6/1/2015 - 7/31/2015 | 44.66% |
ANI Pharmaceuticals (ANIP) | 6/1/2015 - 7/31/2015 | 42.72% |
LeMaitre Vascular (LMAT) | 6/1/2015 - 7/31/2015 | 41.83% |
Green Dot (GDOT) | 6/1/2015 - 7/31/2015 | 40.57% |
Lendingtree (TREE) | 6/1/2015 - 7/31/2015 | 40% |
